We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$79.2B
AUM Growth
+$3.07B
Cap. Flow
-$2.3B
Cap. Flow %
-2.9%
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 27.48%
2 Consumer Discretionary 18.83%
3 Communication Services 18.1%
4 Healthcare 11.79%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.77T
$5.9B 7.44%
43,922,338
-1,927,097
-4% -$266M
TSLA icon
2
Tesla
TSLA
$1.21T
$5.44B 6.87%
13,471,709
-2,650,229
-16% -$853M
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$4.6B 5.8%
7,852,279
-298,803
-4% -$175M
AMZN icon
4
Amazon
AMZN
$2.48T
$4.5B 5.68%
20,514,402
-146,732
-0.7% -$30M
NFLX icon
5
Netflix
NFLX
$301B
$3.6B 4.54%
40,383,020
-2,312,310
-5% -$190M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.08T
$3.57B 4.51%
18,878,229
-29,299
-0.2% -$5.13M
V icon
7
Visa
V
$697B
$3.02B 3.81%
9,552,938
-303,670
-3% -$91.3M
ORCL icon
8
Oracle
ORCL
$346B
$2.92B 3.69%
17,552,543
-684,884
-4% -$122M
MSFT icon
9
Microsoft
MSFT
$2.92T
$2.61B 3.3%
6,196,706
-168,522
-3% -$71.8M
BA icon
10
Boeing
BA
$175B
$2.6B 3.28%
14,693,166
+119,628
+0.8% +$18.8M
CRM icon
11
Salesforce
CRM
$149B
$2.17B 2.74%
6,493,055
-234,679
-3% -$74.9M
ADSK icon
12
Autodesk
ADSK
$50.1B
$1.72B 2.17%
5,816,987
-200,603
-3% -$59.3M
DIS icon
13
Walt Disney
DIS
$172B
$1.59B 2.01%
14,312,144
-486,929
-3% -$51.2M
SHOP icon
14
Shopify
SHOP
$169B
$1.55B 1.96%
14,612,866
-470,344
-3% -$45.7M
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$124B
$1.52B 1.92%
3,772,789
+704,575
+23% +$327M
MNST icon
16
Monster Beverage
MNST
$95.6B
$1.39B 1.75%
26,413,607
-729,363
-3% -$38.7M
REGN icon
17
Regeneron Pharmaceuticals
REGN
$72.9B
$1.12B 1.42%
1,575,349
+393,997
+33% +$331M
NVO
18
Novo Nordisk
NVO
$225B
$995M 1.26%
11,571,686
+2,947,771
+34% +$319M
ISRG icon
19
Intuitive Surgical
ISRG
$130B
$900M 1.14%
1,724,281
-59,042
-3% -$30.8M
QCOM icon
20
Qualcomm
QCOM
$172B
$882M 1.11%
5,741,120
-200,312
-3% -$32.8M
SBUX icon
21
Starbucks
SBUX
$118B
$878M 1.11%
9,619,083
-315,488
-3% -$30.5M
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.07T
$746M 0.94%
3,918,961
-737,793
-16% -$130M
SEIC icon
23
SEI Investments
SEIC
$12.4B
$729M 0.92%
8,837,307
-310,622
-3% -$24.4M
FDS icon
24
Factset
FDS
$10.1B
$722M 0.91%
1,502,324
-50,979
-3% -$24.2M
TMO icon
25
Thermo Fisher Scientific
TMO
$214B
$652M 0.82%
1,253,353
-44,659
-3% -$24.6M

Similar funds

Loomis, Sayles & Company's Q4 2024 Portfolio in Review

As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
  • Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
  • Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
  • Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
  • Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
  • Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.